Autolus Therapeutics (AUTL) Profit After Tax Growth (5y) (2022 - 2025)

Autolus Therapeutics (AUTL) Profit After Tax Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Autolus Therapeutics 393.78 Mn 93.07 Mn -1.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -21.40%
Sep 30, 2025 -17.87%
Jun 30, 2025 -7.19%
Mar 31, 2025 -18.62%
Jun 30, 2024 0.40%
Mar 31, 2024 -14.16%
Dec 31, 2023 -31.73%
Sep 30, 2023 -0.34%
Jun 30, 2023 -8.30%
Dec 31, 2022 -19.43%